I am a
Home I AM A Search Login

Papers of the Week

2020 Aug 19

J Clin Med



Efficacy of Dupilumab on Different Phenotypes of Atopic Dermatitis: One-Year Experience of 221 Patients.


Tavecchio S, Angileri L, Pozzo Giuffrida F, Germiniasi F, Marzano A V, Ferrucci S
J Clin Med. 2020 Aug 19; 9(9).
PMID: 32824992.


The clinical features of adult-onset atopic dermatitis (AD) are heterogeneous and the diagnosis can be a challenge. A new biologic drug (dupilumab) has been approved for moderate to severe AD in adult patients. The efficacy and safety have been demonstrated in clinical trials, but these studies do not reflect conditions in daily practice and do not consider the different clinical manifestations of AD.